Dossier
public-benefit company
Coverage of public-benefit company in the Nexus archive.
- AI giant Anthropic creates drug research tool, plans its own studies for overlooked diseases
Anthropic, an AI company, has developed a drug research tool called Claude Science to accelerate scientific discovery and is launching its own preclinical drug programs for neglected diseases. The company aims to address diseases less profitable for pharmaceutical industries by leveraging its public-benefit status to balance profit with public good.